Guangdong Kanghua Healthcare Group Co., Ltd. (HKG:3689)
Hong Kong · Delayed Price · Currency is HKD 1.790
0.00 (0.00%)
Jul 14, 2025, 1:58 PM HKT
HKG:3689 Revenue
In the year 2024, Guangdong Kanghua Healthcare Group had annual revenue of 2.06B CNY with 0.68% growth. Guangdong Kanghua Healthcare Group had revenue of 1.07B in the half year ending December 31, 2024, with 8.98% growth.
Revenue
2.06B CNY
Revenue Growth
+0.68%
P/S Ratio
0.27
Revenue / Employee
475.85K CNY
Employees
4,320
Market Cap
598.57M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.06B | 13.81M | 0.68% |
| Dec 31, 2023 | 2.04B | 196.23M | 10.63% |
| Dec 31, 2022 | 1.85B | -108.31M | -5.54% |
| Dec 31, 2021 | 1.95B | 208.92M | 11.97% |
| Dec 31, 2020 | 1.75B | -210.50M | -10.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 28.99B |